TIMOTHY MALONE: Open Payments
NPI 1225008832 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 56 payments from 12 companies in 2025. Trend: 2023 $520 · 2024 $801 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $240 |
| ABBVIE INC. | 20 | $165 |
| Bausch Health US, LLC | 6 | $125 |
| Neurocrine BioSciences, Inc. | 3 | $94 |
| Noven Therapeutics, LLC | 5 | $79 |
| Alkermes, Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Lundbeck LLC | 2 | $33 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $21 |
Products named: CAPLYTA, VRAYLAR, APLENZIN, INGREZZA, REXULTI, Xelstrym, LYBALVI, Jornay PM.
Industry payments across SC — which companies pay providers there.
